Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Avalo Therapeutics, Inc./ SCHEDULE 13G/A

SEC Filing · SCHEDULE 13G/A

Avalo Therapeutics, Inc.

AVTXNASDAQEQUITYCurrent

SEC Filing

Filed Aug 14, 2026Accepted Aug 14, 2026, 8:24 AM EDTCIK 1534120Accession 0001172661-26-003475
View company →Permanent SEC source ↗
Share

Company context

Current securities

AVTXNASDAQ · EQUITY · Current
Historical securities (2)
CERCWNASDAQ · WARRANT · Historical · closed Oct 18, 2018CERCZNASDAQ · WARRANT · Historical · closed Apr 18, 2017

Recent company filings

  1. 144 filingAug 17, 2026
  2. SCHEDULE 13G/A filingAug 14, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. SCHEDULE 13G/A filingAug 14, 2026
  5. SCHEDULE 13G/A filingAug 13, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗